Long-term changes in left ventricular hypertrophy after renal transplantation

C Rigatto1, R N Foley, G M Kent

  • 1Division of Nephrology, Memorial University, St. John's Newfoundland, Canada.

Transplantation
|September 6, 2000
PubMed

Insights

Left ventricular hypertrophy regression after kidney transplant continues until year two, then stabilizes. Factors like older age and hypertension predict poor regression, impacting long-term cardiac health in transplant recipients.

Area of Science:

  • Nephrology
  • Cardiology
  • Transplantation Medicine

Background:

  • Left ventricular hypertrophy (LVH) is a common, progressive complication in dialysis patients, linked to adverse cardiac outcomes.
  • While partial LVH regression occurs post-transplant, its long-term trajectory remains unclear.

Purpose of the Study:

  • To investigate the long-term evolution of left ventricular hypertrophy (LVH) after renal transplantation.
  • To identify factors associated with the failure of LVH regression post-transplant.

Main Methods:

  • A prospective cohort study of 143 renal transplant recipients from a larger dialysis patient cohort.
  • Annual echocardiography and monthly laboratory assessments over four years post-transplant.
  • Multiple linear regression analysis to model changes in left ventricular mass index (LVMI).

Main Results:

  • LVMI decreased significantly from year 1 to year 2 post-transplant (161 g/m2 to 146 g/m2), then stabilized.
  • Left ventricular volume index followed a similar pattern, declining by year 2 and stabilizing thereafter.
  • Failure to regress LVMI by year 2 was associated with older age, hypertension, and specific pulse pressure characteristics relative to heart size.

Conclusions:

  • LVH regression extends beyond the first year post-renal transplant, reaching a nadir at two years and persisting.
  • Older age, history of hypertension, and abnormal pulse pressure dynamics are linked to incomplete LVH regression.
Abstract

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...